ClinConnect ClinConnect Logo
Search / Trial NCT00002022

Treatment Program for Anemia in AIDS Patients

Launched by R W JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE · Aug 30, 2001

Trial Information

Current as of March 19, 2025

Completed

Keywords

Recombinant Proteins Drugs, Investigational Erythropoietin Acquired Immunodeficiency Syndrome Anemia Zidovudine

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Exclusion Criteria
  • Co-existing Condition:
  • Patients with the following are excluded:
  • Life expectancy \< 3 months.
  • = or \< grade 4 performance score.
  • AIDS-related dementia.
  • Uncontrolled hypertension.
  • Acute symptomatic opportunistic infection or other AIDS-defining illness.
  • Patients with the following are excluded:
  • Life expectancy \< 3 months.
  • = or \< grade 4 performance score.
  • AIDS-related dementia.
  • Uncontrolled hypertension.
  • Acute symptomatic opportunistic infection or other AIDS-defining illness.
  • Patients must have:
  • A clinical diagnosis of AIDS.
  • Hematocrit \< 30 percent.
  • Endogenous serum erythropoietin level = or \< 500 U/ml.
  • A life expectancy = or \> 3 months.
  • \> Grade 4 performance score.

About R W Johnson Pharmaceutical Research Institute

The R.W. Johnson Pharmaceutical Research Institute is a leading pharmaceutical research organization dedicated to advancing innovative therapeutic solutions that improve patient outcomes. With a strong focus on drug development and clinical trials, the Institute leverages cutting-edge science and technology to discover and evaluate new treatments across a range of medical conditions. Committed to rigorous research methodologies and ethical standards, R.W. Johnson Pharmaceutical Research Institute collaborates with various stakeholders, including academic institutions and healthcare professionals, to drive progress in the pharmaceutical industry and deliver transformative therapies to patients worldwide.

Locations

Raritan, New Jersey, United States

People applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials